Fidji Simo, the former head of applications at OpenAI, has transitioned from her full-time duties to a part-time advisory capacity. This change is a direct result of a protracted recovery period from a persistent health condition. Simo's decision underscores the challenges professionals face when balancing demanding careers with personal well-being, a theme she herself acknowledged by expressing regret over not having prioritized her health sooner. Her move highlights the importance of self-care even in high-stakes corporate environments, impacting OpenAI's leadership structure and drawing attention to the broader issue of executive health.

Simo publicly announced her shift on Thursday, indicating that her journey back to full health from a chronic illness, which she has managed for seven years, required more time than initially projected. This condition led her to take a medical leave three months prior to her announcement. She recounted a past instance where she declined a year-long medical leave from Meta, noting that CEO Mark Zuckerberg had advised her to consider the long-term perspective regarding her health. This anecdote emphasizes the internal and external pressures that can lead individuals to defer critical health decisions.

Her move to a part-time advisory role is part of a series of leadership changes at OpenAI. Following her medical leave in April, Greg Brockman assumed oversight of product responsibilities. Concurrently, Brad Lightcap, OpenAI’s Chief Operating Officer, moved into a new role focusing on specialized projects, with Denise Dresser, the Chief Revenue Officer, taking on many of Lightcap's previous duties. Simo's departure as a full-time executive also aligns with several other high-profile exits from OpenAI this year, including leaders moving to Google and Thrive Capital.

Despite stepping back from a full-time operational role, Simo remains dedicated to advancing disease research. She confirmed her ongoing commitment to this cause through her advisory role at OpenAI and her continued involvement with Chronicle BioAI and CODA Research. Her professional journey, which includes her tenure as CEO of Instacart before joining OpenAI as applications chief in May 2025, showcases a career marked by significant leadership in technology, now adapting to personal health imperatives while still aiming to contribute to important scientific endeavors.

The transition of Fidji Simo from a full-time executive position at OpenAI to a part-time advisory role illustrates the critical intersection of professional demands and personal health. Her candid admission about delaying necessary health-related decisions serves as a significant reflection point for high-achieving individuals. This shift, driven by a prolonged recovery from a chronic illness, not only reconfigures a key leadership role within OpenAI but also highlights an organizational adaptation to support an executive's well-being. Simo's continued engagement in disease research, even in a modified capacity, demonstrates a persistent commitment to her passions despite personal challenges.